aid: acepodia
name: Acepodia
description: 'Acepodia is a clinical-stage biotechnology company founded in 2017 by
  Dr. Patrick Y. Yang and Dr. Sonny Hsiao, headquartered in Alameda, California with
  operations in Taipei, Taiwan. It develops off-the-shelf allogeneic cell therapies
  for cancer and autoimmune disease built on two proprietary platforms: Antibody-Cell
  Conjugation (ACC), which uses bioorthogonal click chemistry from Carolyn Bertozzi''s
  Nobel Prize-winning work to attach tumor-targeting antibodies to gamma delta 2 T
  cells and natural killer cells without genetic engineering, and Antibody-Dual-Drugs
  Conjugation (AD2C). Its clinical pipeline includes ACE1831, an anti-CD20 gamma delta
  T cell therapy, and ACE2016, an anti-EGFR gamma delta T cell therapy. Acepodia is
  a therapeutics developer rather than a software vendor, and publishes no public API,
  developer portal, or machine-readable specification.'
image: https://www.acepodia.com/upload/base_fb_img/enL_01ns_web_base_20K06_uiwbgs3abs.png
url: https://raw.githubusercontent.com/api-evangelist/acepodia/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: stub
x-tier-reason: harvest
specificationVersion: '0.23'
created: '2026-08-06'
modified: '2026-08-06'
tags:
- Company
- Biotechnology
- Cell Therapy
- Oncology
- Immunotherapy
- Life Sciences
- Clinical Stage
- Healthcare
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://www.acepodia.com/
- type: About
  url: https://www.acepodia.com/about/
- type: Contact
  url: https://www.acepodia.com/contact/
- type: Careers
  url: https://www.acepodia.com/careers/
- type: Leadership
  url: https://www.acepodia.com/leadership/
- type: Technology
  url: https://www.acepodia.com/technology/
- type: Pipeline
  url: https://www.acepodia.com/pipeline/
- type: Partnerships
  url: https://www.acepodia.com/partnerships/
- type: News
  url: https://www.acepodia.com/newsroom/
- type: PressReleases
  url: https://www.acepodia.com/newsroom/press-releases/
- type: PrivacyPolicy
  url: https://www.acepodia.com/legal/privacy/
- type: TermsOfService
  url: https://www.acepodia.com/legal/terms-of-use/
- type: LinkedIn
  url: https://www.linkedin.com/company/acepodia/
- type: DomainSecurity
  url: security/acepodia-domain-security.yml
- type: WellKnown
  url: well-known/acepodia-well-known.yml
- type: LLMsTxt
  url: llms/acepodia-llms.txt
- type: SecondaryMarket
  url: https://forgeglobal.com/acepodia_stock/
x-enrichment:
  date: '2026-08-06'
  status: minimal
  artifacts_added: 3
  pass: local-v1
x-coverage:
  state: none
  reason: not-a-software-company
  detail: >-
    Acepodia is a clinical-stage cell-therapy developer whose published sitemap.xml lists 38 URLs,
    every one of them corporate (about, leadership, technology, pipeline, newsroom, partnerships,
    careers, legal) — no api., developer., docs., portal., app., status. or trust. host resolves for
    acepodia.com, no acepodia GitHub organisation exists, and every /.well-known/ and conventional
    spec path on www.acepodia.com returns the site's own HTML 404 page.
  evidence:
  - url: https://www.acepodia.com/sitemap.xml
    status: 200
  - url: https://www.acepodia.com/openapi.json
    status: 404
  - url: https://www.acepodia.com/.well-known/agent-card.json
    status: 404
  - url: https://www.acepodia.com/.well-known/security.txt
    status: 404
  - url: https://www.acepodia.com/llms.txt
    status: 404
  - url: https://api.github.com/orgs/acepodia
    status: 404
  checked: '2026-08-06'